Cancer Immunotherapy (placement option available) - MSc	University of Hertfordshire	School of Life and Medical Science	['Full Time']	Why choose Herts?Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy.Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.About the courseThe use of the immune system in cancer therapy is a prevailing ambition in the field. You’ll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We’ll provide a thorough understanding of immune effector mechanisms and cancer biology. You’ll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.	See Course	UK Students Full time: £12400 for 2022/2023 and 2023/2024 inclusive  EU/International Students Full time: £16650 for 2022/2023 and 2023/2024 inclusive	MSc	2 years full time (sandwich course)	Hatfield	United Kingdom	On Campus	https://www.findamasters.com/masters-degrees/course/cancer-immunotherapy-placement-option-available-msc/?i313d1157c61832
